Übermäßiges Körpergewicht und Krebsrisiko

Zusammenfassung

Übermäßiges Körpergewicht (ÜKG) stellt derzeit die zweitwichtigste vermeidbare Krebsursache in Deutschland dar. Für viele Karzinome ist eine Dosis-Wirkungs- Beziehung belegt, d. h. je ausgeprägter das ÜKG, desto größer ist das Krebsrisiko. Bedenklich: Etwa 60% der erwachsenen Bundesbürger weisen ein ÜKG auf und mehr als 23% sind adipös. Mittlerweile sind von ÜKG-assoziierten Tumoren immer öfter 20–40-Jährige betroffen.

Abstract

Excess body weight (EBW) is the second most important and potentially modifiable risk factor of cancer in Germany. The longer and the more excess body weight a person has, the higher the cancer risk. About 60% of adult Germans have EBW (BMI≥25.0 kg/m²) and more than 23% are obese (BMI≥30.0 kg/m²). Excess body weight is causally associated with colorectal, esophageal (adenocarcinoma), gastric (cardia), pancreatic, biliary, hepatocellular, kidney, thyroid, breast (postmenopausal), endometrial and ovarian cancer as well as multiple myeloma and meningioma. In recent years, more and more young adults (20–40 years) were diagnosed with EBW-associated tumors. People with EBW should be encouraged to join programs of cancer screening. Keeping a healthy weight is a major public health concern in Germany.

Schlüsselwörter

Darmkrebs - Ösophaguskarzinom - Magentumor - Pankreasneoplasie - Leberkrebs

Key words

colorectal - esophageal - gastric - pancreatic - biliary cancer

Publication History

Article published online:
07 March 2022

• Literatur

• 1 Sung H, Siegel R, Torre L. et al. Global patterns in excess body weight and the associated cancer burden. CA Cancer J Clin 2019; 69: 88-112 DOI: 10.3322/caac.21499.
• 2 Robert-Koch-Institut. Gesundheitsmonitoring. Übergewicht und Adipositas. Im Internet (Stand: 02.02.2020): www.rki.de/DE/Content/Gesundheitsmonitoring/Themen/Uebergewicht_Adipositas/Uebergewicht_Adipositas_node.html
• 3 Deutsche Adipositas-Gesellschaft. Prävalenz von Übergewicht und Adipositas. Im Internet (Stand: 02.02.2020): www.adipositas-gesellschaft.de/index.php?id=41
• 4 Diabetesinformationsdienst München. Wie häufig ist Adipositas? Im Internet (Stand: 02.02.2020): www.diabetesinformationsdienst-muenchen.de/erkrankungsformen/adipositas/verbreitung/index.html
• 5 Mensink G, Schienkiewitz A, Haftenberger M. et al. Übergewicht und Adipositas in Deutschland. Bundesgesundheitsbl 2013; 56: 786-794 DOI: 10.1007/s00103-012-1656-3.
• 6 Cancer Research UK . Obese people outnumber smokers two to one. Im Internet (Stand: 02.02.2020): www.cancerresearchuk.org/about-us/cancer-news/press-release/2019-07-03-obese-people-outnumber-smokers-two-to-one
• 7 Steele CB, Thomas CC, Henley SJ. et al. Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity – United States, 2005-2014. MMWR 2017; 66: 1052-1058 DOI: 10.15585/mmwr.mm6639e1.
• 8 Lauby-Secretan B, Scoccianti C, Loomis D. et al. Body fatness and cancer – viewpoint of the IARC Working Group. N Engl J Med 2016; 375: 794-798 DOI: 10.1056/NEJMsr1606602.
• 9 Cancer Research UK . Obesity, weight and cancer. Im Internet (Stand: 02.02.2020): https://www.cancerresearchuk.org/about-cancer/causes-of-cancer/obesity-weight-and-cancer
• 10 Anderson AS, Key TJ, Norat T. et al. European Code Against Cancer 4th Edition: obesity, body fatness and cancer. Cancer Epidemiol 2015; 39: S34-S45 DOI: 10.1016/j.canep.2015.01.017.
• 11 World Cancer Research Fund/American Institute for Cancer Research . Continuous Update Project Expert Report 2018. Body fatness and weight gain and the risk of cancer. Im Internet (Stand: 02.02.2020): www.dietandcancerreport.org
• 12 Avgerinos KI, Spyrou N, Mantzoros C. et al. Obesity and cancer risk: Emerging biological mechanisms and perspectives. Metabolism 2019; 92: 121-135 DOI: 10.1016/j.metabol.2018.11.001.
• 13 Shrotriya S, Walsh D, Nowacki AS. et al. Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors. PLoS One 2018; 13: e0202555 DOI: 10.1371/journal.pone.0202555.
• 14 Codipilly D, Chandar A, Singh S. et al. The effect of endoscopic surveillance in patients with Barrett's esophagus: A systematic review and meta-analysis. Gastroenterol 2018; 154: 2068-2086 e5 DOI: 10.1053/j.gastro.2018.02.022.
• 15 Sumiyama K. Past and current trends in endoscopic diagnosis for early stage gastric cancer in Japan. Gastric Cancer 2017; 20: 20-27 DOI: 10.1007/s10120-016-0659-4.
• 16 Sung H, Siegel R, Rosenberg P. et al. Emerging cancer trends among young adults in the USA: analysis of a populationbased cancer registry. Lancet Public Health 2019; 4: e137-e147 DOI: 10.1016/S2468-2667(18)30267-6.
• 17 Vuik F, Nieuwenburg S, Bardou M. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019; 68: 1820-1826 DOI: 10.1136/gutjnl-2018-317592.
• 18 Levi Z, Kark JD, Katz L. et al. Adolescent body mass index and risk of colon and rectal cancer in a cohort of 1.79 million Israeli men and women: A population-based study. Cancer 2017; 123: 4022-4030 DOI: 10.1002/cncr.30819.
• 19 Loomba R, Yang H, Su J. et al. Synergism between obesity and alcohol in increasing the risk of hepatocellular carcinoma: a prospective cohort study. Am J Epidemiol 2013; 177: 333-342 DOI: 10.1093/aje/kws252.
• 20 Deutsche Krebsgesellschaft . Leberkrebs – Ursachen und Risikofaktoren. Im Internet (Stand: 02.02.2020): www.krebsgesellschaft.de/onko-internetportal/basis-informationen-krebs/krebsarten/andere-krebsarten/leberkrebs/risiko-und-ursache.html
• 21 Yu M, Lin C, Liu C. et al. Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death inmen with chronic hepatitis B: A large cohort study. Gastroenterol 2017; 153: 1006-1017 DOI: 10.1053/j.gastro.2017.07.001.
• 22 Meyer J, Rohrmann S, Bopp M. et al. Swiss National cohort study group. Impact of smoking and excess body weight on overall and site-specific cancer mortality risk. Cancer Epidemiol Biomarkers Prev 2015; 24: 1516-1522 DOI: 10.1158/1055-9965.EPI-15-0415.
• 23 Scherübl H, Seitz HK. Lebensführung und gastroenterologische Erkrankungen. In: Lammert F, Lynen Jansen P, Lerch MM, Hrsg. Weißbuch Gastroenterologische Erkrankungen 2020/2021. Berlin/Boston: Walter de Gruyter; 2019: 256-259
• 24 Landberg A, Fält A, Montgomery S. et al. Overweight and obesity during adolescence increases the risk of renal cell carcinoma. Int J Cancer 2019; 145: 1232-1237 DOI: 10.1002/ijc.32147.
• 25 MacKintosh M, Derbyshire A, McVey R. et al. The impact of obesity and bariatric surgery on circulating and tissue biomarkers of endometrial cancer risk. Int J Cancer 2019; 144: 641-650 DOI: 10.1002/ijc.31913.
• 26 Wiggins T, Antonowicz S, Markar S. Cancer risk following bariatric surgery – systematic review and meta-analysis of national population-based cohort studies. Obes Surg 2019; 29: 1031-1039 DOI: 10.1007/s11695-018-3501-8.
• 27 Mackenzie H, Markar S, Askari A. et al. Obesity surgery and risk of cancer. Br J Surg 2018; 105: 1650-1657 DOI: 10.1002/bjs.10914.
• 28 Tsilidis K, Kasimis J, Lopez D. et al. Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 2015; 350: 7607 DOI: 10.1136/bmj.g7607.
• 29 Tran C. Diabetes, cancer and obesity: unequivocal association. Rev Med Suisse 2019; 15: 1112-1116
• 30 Brenner H, Mons U. Krebs. Große Potenziale der Prävention. Dtsch Arztebl 2019; 116: A132-A133
• 31 Wienecke A, Neuhauser H, Kraywinkel K. et al. Cancers potentially preventable through excess weight reduction in Germany in 2010. Obes Facts 2018; 11: 400-412 DOI: 10.1159/000490150.
• 32 Scherübl H. Alkoholkonsum und Krebsrisiko. DMW 2019; 144: 1354-1360 DOI: 10.1055/a-0928-0586.
• 33 Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014 348. g2467 CrossRef MEDLINE PubMed Central